Pharmacy budget slashed by £200 million over two years.
European Medicines Agency proactively publishes clinical study reports for first time.
This week’s news
Pfizer taking on J&J’s blockbuster Remicade.
NICE, regulator and NHS should work together, according to review.
Extra funding brings series B financing round to $45 million total.
Swiss biotech looks to combine small molecule drug with immunotherapy.
$21.5 million in funding will be used to expand its existing roster of digitally-guided therapy solutions.
A decisive moment in lung cancer treatment is nearing
Funds will go towards the final development of its smartloop solution.
Drug approved in metastatic adenocarcinoma of the pancreas.
Backed by Amgen, Kite outlines bold plan for developing CAR-T and TCR cells.
Avacta is one of several biotechs turning their backs on mabs.
Pfizer’s rival launch should be considered “at risk”, says J&J
Cancer immunotherapy approved in second line.